The Changing Landscape of Axial Spondyloarthritis: Current and Emerging Agents for Individualized Treatment
Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues who you believe would be interested in attending this free educational program.
Le Méridien Philadelphia
1421 Arch Street
Philadelphia, PA, 19102
Meeting Room: Trumbauer
– Virtual Reality headsets provided to all attendees for viewing this presentation only
– Interactive, case-based learning environment
– Create your own personalized poster
– iPads provided to enhance learning experience and enable real-time Q&A
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Neal S. Birnbaum, MD
Director, Division of Rheumatology
California Pacific Medical Center
San Francisco, CA
After completing the CME activity, learners should be better able to:
- Examine the specific domains of AxSpA and their relationship to quality of life
- Review current and emerging therapies used for AxSpA
- Evaluate the IL-17/23 axis and its relationship to the pathophysiology of AxSpA
- Compare outcomes measures used in clinical trials versus those that may be more practical for use in clinical practice
This activity is intended for rheumatologists and other healthcare professionals involved in the management of patients with axial spondyloarthritis.
This CME activity is planned and produced in accordance with ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with axial spondyloarthritis..
CNE Credits:1.5 ANCC Contact Hour(s)
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]